HWM
IONS icon

Hemington Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Hemington Wealth Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2K Sell
42
-2
-5% -$98 ﹤0.01% 1337
2025
Q2 		$1K Sell
44
-14
-24% -$458 ﹤0.01% 1418
2025
Q1 		$1K Sell
58
-25
-30% -$819 ﹤0.01% 1405
2024
Q4 		$2K Sell
83
-1
-1% -$37 ﹤0.01% 1279
2024
Q3 		$3K Buy
+84
New +$3.91K ﹤0.01% 1077

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hemington Wealth Management's IONS Position: Q3 2025 in Review

Hemington Wealth Management reduced its Ionis Pharmaceuticals (IONS) stake by 4.5% in Q3 2025, selling an estimated $98 and leaving 42 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1337.

Hemington Wealth Management first reported a position in IONS in Q3 2024 and has held it in 5 quarters since. The position peaked at $3K in Q3 2024. 435 funds tracked by Wall St. Rank hold IONS as of Q3 2025.

  • Hemington Wealth Management held 42 shares of Ionis Pharmaceuticals worth $2K as of Q3 2025.
  • Hemington Wealth Management sold 2 Ionis Pharmaceuticals shares in Q3 2025, an estimated $98.
  • Ionis Pharmaceuticals made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1337 holding.
  • Hemington Wealth Management first reported a position in Ionis Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • Hemington Wealth Management's Ionis Pharmaceuticals position peaked at $3K in Q3 2024.
  • 435 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.